Henry Schein

Henry Schein, Inc., a US-headquartered wholesaler of medical, dental, and hospital equipment and supplies, has made significant climate commitments, including setting Science Based Targets initiative (SBTi) approved goals.

For 2025, Henry Schein reported total Scope 1 emissions of approximately 37,048,000 kg CO2e, Scope 2 emissions (market-based) of approximately 16,627,000 kg CO2e, and Scope 3 emissions of approximately 3,052,762,000 kg CO2e. Key contributors to Scope 3 emissions include purchased goods and services (approximately 2,406,465,000 kg CO2e) and end-of-life treatment of sold products (approximately 152,085,000 kg CO2e).

The company has set ambitious Science Based Targets:

• Near-term:
  • Reduce absolute Scope 1 greenhouse gas (GHG) emissions by 42% by 2030, using a 2022 base year.
  • Increase active annual sourcing of renewable electricity from 0% in 2022 to 100% by 2030.
  • Reduce Scope 3 GHG emissions by 51.6% per million USD value added (gross profit) by 2030, using a 2022 base year.
• Long-term:
  • Reduce absolute Scope 1 GHG emissions by 90% by 2050, using a 2022 base year.
  • Continue active annual sourcing of 100% renewable electricity through 2030.
  • Reduce Scope 3 GHG emissions by 97% per million USD value added (gross profit) by 2050, using a 2022 base year.

Henry Schein is committed to achieving net-zero greenhouse gas emissions across its entire value chain by 2050. These targets, covering Scope 1, 2, and 3 emissions, are consistent with the reductions required to limit global warming to 1.5°C.